News
According to Benzinga Pro, Globus Medical's peer group average for short interest as a percentage of float is 4.39%, which ...
1d
Investor's Business Daily on MSNGlobus Medical Sees Relative Strength Rating Improve To 73Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
StockStory.org on MSN1d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
Learn more about whether Globus Medical, Inc. or LeMaitre Vascular, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Globus Medical GMED has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. Summarizing their recent assessments, the table ...
Schedule 1 features a large map packed full of important locations you’ll need to visit as you look to expand your criminal operation, but it can be hard to remember where everything is.
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts' stance ...
On Thursday, JMP analysts maintained their Market Perform rating for Globus Medical (NYSE:GMED) stock, currently trading at $74.28 with a market capitalization of $10.22 billion. The analysts ...
Wondering where to find the Verdansk safe locations? The return of Verdansk is very exciting: not only is the original Warzone map arguably the best there’s ever been, Warzone is receiving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results